Apellis Pharmaceuticals, Inc. (DELISTED) (APLS:DL)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
Apellis Pharmaceuticals Free Cash Flow : 37.47M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.316B |
| Eli Lilly & Co. | 10.37B |
| Agios Pharmaceuticals, Inc. | -384.73M |
| Spyre Therapeutics, Inc. | -185.87M |
| Scholar Rock Holding Corp. | -303.86M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -60.97M |
| Cash from Financing (Quarterly) | 0.064M |
| Free Cash Flow Per Share (Quarterly) | -0.4639 |
| Free Cash Flow to Equity (Quarterly) | -62.36M |
| Free Cash Flow to Firm (Quarterly) | -50.92M |
| Free Cash Flow Yield | 0.71% |